title: Reversal of anemia with allogenic RBC transfusion prevents post-cardiopulmonary bypass acute kidney injury in swine.
abstract: Anemia during cardiopulmonary bypass (CPB) is strongly associated with acute kidney injury in clinical studies; however, reversal of anemia with red blood cell (RBC) transfusions is associated with further renal injury. To understand this paradox, we evaluated the effects of reversal of anemia during CPB with allogenic RBC transfusion in a novel large-animal model of post-cardiac surgery acute kidney injury with significant homology to that observed in cardiac surgery patients. Adult pigs undergoing general anesthesia were allocated to a Sham procedure, CPB alone, Sham+RBC transfusion, or CPB+RBC transfusion, with recovery and reassessment at 24 h. CPB was associated with dilutional anemia and caused acute kidney injury in swine characterized by renal endothelial dysfunction, loss of nitric oxide (NO) bioavailability, vasoconstriction, medullary hypoxia, cortical ATP depletion, glomerular sequestration of activated platelets and inflammatory cells, and proximal tubule epithelial cell stress. RBC transfusion in the absence of CPB also resulted in renal injury. This was characterized by endothelial injury, microvascular endothelial dysfunction, platelet activation, and equivalent cortical tubular epithelial phenotypic changes to those observed in CPB pigs, but occurred in the absence of severe intrarenal vasoconstriction, ATP depletion, or reductions in creatinine clearance. In contrast, reversal of anemia during CPB with RBC transfusion prevented the reductions in creatinine clearance, loss of NO bioavailability, platelet activation, inflammation, and epithelial cell injury attributable to CPB although it did not prevent the development of significant intrarenal vasoconstriction and endothelial dysfunction. In conclusion, contrary to the findings of observational studies in cardiac surgery, RBC transfusion during CPB protects pigs against acute kidney injury. Our study underlines the need for translational research into indications for transfusion and prevention strategies for acute kidney injury.
authors.affiliation: Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, UK.
authors.forename: Nishith N
authors.initials: NN
authors.lastname: Patel
authors.forename: Hua
authors.initials: H
authors.lastname: Lin
authors.forename: Tibor
authors.initials: T
authors.lastname: Toth
authors.forename: Gavin I
authors.initials: GI
authors.lastname: Welsh
authors.forename: Ceri
authors.initials: C
authors.lastname: Jones
authors.forename: Paramita
authors.initials: P
authors.lastname: Ray
authors.forename: Simon C
authors.initials: SC
authors.lastname: Satchell
authors.forename: Philippa
authors.initials: P
authors.lastname: Sleeman
authors.forename: Gianni D
authors.initials: GD
authors.lastname: Angelini
authors.forename: Gavin J
authors.initials: GJ
authors.lastname: Murphy
mesh_terms: D058186:Acute Kidney Injury / Q000209:etiology* / Q000378:metabolism / Q000517:prevention & control*; D000740:Anemia / Q000628:therapy*; D000818:Animals; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D003404:Creatinine / Q000378:metabolism; D017707:Erythrocyte Transfusion; D005260:Female; D007677:Kidney Function Tests; D023421:Models, Animal; D009569:Nitric Oxide / Q000378:metabolism; D015539:Platelet Activation / Q000502:physiology; D013552:Swine; D016896:Treatment Outcome
chemical_list: D009569:Nitric Oxide; D003404:Creatinine